Evidence map›Paper›PMID 39890916›Full record

ArticleScientific reports2025

Mesalazine solubility in supercritical carbon dioxide with and without cosolvent and modeling.

Seyed Ali Sajadian, Nadia Esfandiari, Adrián Rojas, Salar Hemmati, Abolghasem Jouyban, Gonzalo Aguila, Chandrasekhar Garlapati

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Seyed Ali SajadianDepartment of Chemical Engineering, Faculty of Engineering, University of Kashan, Kashan, 87317-53153, Iran.
Nadia EsfandiariDepartment of Chemical Engineering, Marvdasht Branch, Islamic Azad University, Marvdasht, 73711-13119, Iran.
Adrián RojasPackaging Innovation Center (LABEN), Department of Science and Food Technology, Faculty of Technology, University of Santiago of Chile (USACH), Obispo Umaña 050, 9170201, Santiago, Chile.
Salar HemmatiDrug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, 51664-14766, Iran.
Abolghasem JouybanPharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, 51664-14766, Iran.
Gonzalo AguilaDepartamento de Ciencias de La Ingeniería, Facultad de Ingeniería, Universidad Andres Bello, Antonio Varas 880, Santiago, Chile.
Chandrasekhar GarlapatiDepartment of Chemical Engineering, Puducherry Technological University, Puducherry, 605014, India. chandrasekhar@ptuniv.edu.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, the solubility of mesalazine in supercritical carbon dioxide with and without cosolvent was carried out for the first time at different temperatures and pressure values ranging from 308 to 338 K and 12 to 30 MPa, respectively. The determined experimental molar solubilities of mesalazine in supercritical carbon dioxide were in the range of 4.41 × 10

Indexed as

CosolventDensity modelsMesalazineNew association modelSolubilitySupercritical carbon dioxide

Identifiers

PMID39890916
PMCPMC11785961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.